Doe v. Wyeth-Ayerst Laboratories

878 F. Supp. 972, 1995 U.S. Dist. LEXIS 3664
CourtDistrict Court, E.D. Texas
DecidedMarch 17, 1995
DocketNo. 1:94 CV 5006
StatusPublished
Cited by2 cases

This text of 878 F. Supp. 972 (Doe v. Wyeth-Ayerst Laboratories) is published on Counsel Stack Legal Research, covering District Court, E.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Doe v. Wyeth-Ayerst Laboratories, 878 F. Supp. 972, 1995 U.S. Dist. LEXIS 3664 (E.D. Tex. 1995).

Opinion

MEMORANDUM OPINION AND ORDER GRANTING PLAINTIFFS’ MOTION TO REMAND

SCHELL, Chief Judge.

Before this court is Plaintiffs’ Motion for Ruling on Magistrate’s Recommendation for Remand, filed on February 1, 1995. Defendants American Home Products Corporation and Wyeth-Ayerst Laboratories’ response was timely filed on February 23, 1995. A reply thereto was filed on March 6,1995, and a surreply was filed on March 9,1995. Upon consideration of the motion, responses, and attached exhibits, the court is of the opinion that the motion should be GRANTED.

BACKGROUND

The Plaintiffs originally filed this suit as a class action in Illinois state court on September 13, 1993. Subsequently, Plaintiffs filed their Third Amended Complaint on August 18, 1994. In response, the Defendants removed this case to the United States District Court for the Northern District of Illinois on September 1, 1994. Finally, the Plaintiffs filed their motion to remand this action back to state court. United States District Judge Charles R. Norgle, Jr. referred the motion to Magistrate Judge Elaine Bucklo, who recommended that Plaintiffs’ motion be granted. Wyeth-Ayerst next filed its Objections to Magistrate Judge Bucklo’s Report and Recommendation, and Judge Norgle elected to allow this court the opportunity to remand this action.1

FACTS

Defendants sold silicone-coated levonorgestrel implants (“NORPLANT”) to hospitals and physicians who placed them in the bodies of patients. Plaintiffs filed this case as a class action on behalf of those patients who experienced problems which they associ[974]*974ate with NORPLANT. Plaintiffs seek to hold Defendants liable for both the side effects or adverse reactions allegedly caused by NORPLANT and the alleged difficulty of removing NORPLANT once it has been implanted, along with any associated mental anguish.

Plaintiffs’ Second Amended Complaint contained nine counts on behalf of the entire class2 and seventeen counts on behalf of different individuals. The class claims, while focusing on the alleged difficulties surrounding the removal of NORPLANT, included boilerplate, nearly identical prayers for relief, which sought, among other things, class certification, general and special damages, creation of a common fund on behalf of the class, and. attorneys fees and costs. Further, Plaintiffs argued that punitive damages should be awarded. However, in an apparent attempt to avoid federal diversity jurisdiction, Plaintiffs brought the action on behalf of all .women in the United States “who havé had the NORPLANT inserted in their bodies and who have sustained damages of less than $50,000.” Second Amended Complaint ¶55.

Nevertheless, Plaintiffs were still not completely satisfied with their claims and filed a Third Amended Complaint, removing the damages cap from the' class allegations. Third Amended Complaint ¶ 95. This complaint also realleges the same nine counts on behalf of the class and the seventeen counts on behalf of individuals as in the Second Amended Complaint, while adding to these counts allegations concerning the risks of surgery and associated scarring, the risk of undisclosed side effects, and the undisclosed severity of the disclosed side effects. Further, the Third Amended Complaint adds a class claim for Negligent Infliction of Emotional Distress. Finally, the Third Amended Complaint uses virtually the same boilerplate prayers for relief as in the Second Amended Complaint.

DISCUSSION

Plaintiffs argument in favor of remanding this case is twofold: (1) diversity jurisdiction does not exist because not all plaintiffs in the class have claims which satisfy the minimum jurisdictional amount for diversity jurisdiction; and (2) even if diversity jurisdiction does exist, the Defendants have waived their right to remove this action because they waited more than 30 days to remove this action after a complaint first stated a removable claim. Because this court holds that Defendants have waived their right to remove, this order does not address whether the requirements for diversity jurisdiction were ever satisfied, but rather assumes that they were without deciding such.

Before discussing the issue of waiver of right to remove, this court must first consider the threshold matter of which Circuit’s law is to be applied.3 The question of whether to apply the interpretation of 28 U.S.C. § 1446(b) given by the Fifth Circuit or by the Seventh Circuit in a case transferred pursuant to 28 U.S.C. § 1407 appears to be an issue of first impression. However, the District of Columbia Circuit has addressed a similar issue, which this court is able to use to enlighten its decision on this point.

The United States District Court for the District of Columbia was the transferee court, chosen by the Judicial Panel on Multidistrict Litigation, which handled the pretrial proceedings for the actions arising out of the downing of a Korean Air Lines aircraft by Soviet Union military aircraft. In re Korean Air Lines Disaster of Sept. 1, 1983, 829 F.2d 1171, 1172 (D.C.Cir.1987), aff'd, 490 U.S. 122, 109 S.Ct. 1676, 104 L.Ed.2d 113 (1989). On appeal, the Court of Appeals dealt with the issue of which Circuit’s interpretation of fed[975]*975eral law should apply upon transfer under 28 U.S.C. § 1407,4 the circuit in which the transferee court sits or that in which the transfer- or court sits. Id. at 1173. In a thorough opinion written by now-Justice Ginsburg, the Court of Appeals held that the law in the transferee court should apply to federal claims transferred under § 1407, stating,

The federal courts spread across the country owe respect to each other’s efforts and should strive to avoid conflicts, but each has an obligation to engage independently in reasoned analysis. Binding precedent for all is set only by the Supreme Court, and for the district courts within a circuit, only by the court of appeals for that circuit.

Id. at 1176. Further, the court stated, “[W]e are persuaded by thoughtful commentary that ‘the transferee court [should] be free to decide a federal claim in the manner it views as correct without deferring to the interpretation of the transferor circuit.’ ” Id. at 1174 (quoting Marcus, Conflict Among Circuits and Transfers Within the Federal Judicial System, 93 Yale L.J. 677, 721 (1984)).

Applying the rule as set out by the District of Columbia Court of Appeals to our case, since federal removal and remand law is at issue, it is necessary that this court look first to Fifth Circuit law as a guide. All that being said, it should be noted that this court has found that precedent within the Fifth Circuit on this point does itself look to the law of the Seventh Circuit (the transferor court’s circuit) for its support. See In re Shaffer, 42 B.R. 522, 525 (N.D.Tex.1984) (citing Wilson v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bueno v. Wyeth-Ayerst Laboratories
915 F. Supp. 845 (E.D. Texas, 1996)
In Re Norplant Contraceptive Prod. Liability Litig.
878 F. Supp. 972 (E.D. Texas, 1995)

Cite This Page — Counsel Stack

Bluebook (online)
878 F. Supp. 972, 1995 U.S. Dist. LEXIS 3664, Counsel Stack Legal Research, https://law.counselstack.com/opinion/doe-v-wyeth-ayerst-laboratories-txed-1995.